» Articles » PMID: 32321901

Expressions of Vascular Endothelial Growth Factor Receptors, Flk1 and Flt1, in Rat Skin Mast Cells During Development

Overview
Journal J Vet Med Sci
Date 2020 Apr 24
PMID 32321901
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Vascular endothelial growth factor-A (VEGF-A) is a principal regulator of hematopoiesis as well as angiogenesis. However, the functions of VEGF-A and its receptors (VEGFRs) in the differentiation of mast cells (MCs) in the skin remain unclear. The aim of this study was to determine the expression patterns of two VEGFRs (Flk1 and Flt1) in the skin MCs during development and maturation in rats. From the 17th days of embryonic development (E17) to 1 day after birth (Day 1), most of skin MCs were immature cells containing predominant alcian blue (AB) rather than safranin O (SO) granules (AB>SO MCs). AB>SO MC proportions gradually decreased, while mature AB<SO MC proportions increased from Day 7 to 28. Flk1 MC proportions increased from E20 and reached to approximately 90% from Day 1 to 21, thereafter decreased to about 10% at Day 60 and 90. Flk1 MC proportions changed almost in parallel with the numbers of MCs and Ki67 MC proportions from E17 to Day 90. The proportions of MCs with both nuclear and cytoplasmic Flt1-immunoreactivity were markedly increased at Day 28, when the proportions of nuclear Flk1, Ki67, and AB>SO MCs had significantly decreased, and AB<SO MC proportions significantly increased. Considering that the main function of Flt1 is suppression of Flk1 effects, our results indicated that cross-talk between Flk1 and Flt1 regulates the proliferation and maturation of the skin MCs during late embryonic and neonatal development in rats.

Citing Articles

Mast Cell Activation Syndrome Update-A Dermatological Perspective.

Mihele D, Nistor P, Bruma G, Mitran C, Mitran M, Condrat C J Pers Med. 2023; 13(7).

PMID: 37511729 PMC: 10381535. DOI: 10.3390/jpm13071116.


Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation?.

Voss M, Kotrba J, Gaffal E, Katsoulis-Dimitriou K, Dudeck A Int J Mol Sci. 2021; 22(9).

PMID: 33925601 PMC: 8123885. DOI: 10.3390/ijms22094589.

References
1.
Ferrara N, Chen H, Dowd M, Lu L, OShea K, Hillan K . Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996; 380(6573):439-42. DOI: 10.1038/380439a0. View

2.
Mousavi S, Skjeldal F, Fonhus M, Haugen L, Eskild W, Berg T . Receptor-Mediated Endocytosis of VEGF-A in Rat Liver Sinusoidal Endothelial Cells. Biomed Res Int. 2019; 2019:5496197. PMC: 6754870. DOI: 10.1155/2019/5496197. View

3.
Wang Z, Mascarenhas N, Eckmann L, Miyamoto Y, Sun X, Kawakami T . Skin microbiome promotes mast cell maturation by triggering stem cell factor production in keratinocytes. J Allergy Clin Immunol. 2016; 139(4):1205-1216.e6. PMC: 5385284. DOI: 10.1016/j.jaci.2016.09.019. View

4.
Santos S, Miguel C, Domingues I, Calado A, Zhu Z, Wu Y . VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing. Exp Cell Res. 2007; 313(8):1561-74. DOI: 10.1016/j.yexcr.2007.02.020. View

5.
Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W . Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest. 2000; 106(4):511-21. PMC: 380247. DOI: 10.1172/JCI8978. View